INVESTIGATING THE ASSOCIATION BETWEEN HYPOTHYROIDISM AND BREAST CANCER PROGNOSIS IN WOMEN UNDERGOING ENDOCRINE THERAPY: A NARRATIVE REVIEW
DOI:
https://doi.org/10.71000/2yy5ze78Keywords:
Hypothyroidism, Breast Cancer, Endocrine Therapy, Radiation Toxicity, Thyroid Hormone Replacement, Narrative ReviewAbstract
Background: Hypothyroidism is a prevalent endocrine disorder that may affect treatment outcomes in breast cancer patients, particularly those receiving endocrine therapy. As both conditions commonly coexist in women and share hormonal pathways, understanding their interaction is increasingly relevant to clinical decision-making and survivorship care.
Objective: This narrative review aims to explore the influence of hypothyroidism on prognosis, recurrence, and therapeutic outcomes in women undergoing endocrine therapy for breast cancer.
Main Discussion Points: The review synthesizes recent evidence across several key themes: the impact of radiation-induced hypothyroidism, the biological role of thyroid hormones in breast cancer progression, and the potential influence of thyroid hormone replacement—particularly levothyroxine—on endocrine therapy efficacy. It also addresses the limitations of current studies, including methodological inconsistencies, limited prospective data, and poor generalizability. Mechanistic insights suggest a complex interaction between thyroid and estrogen receptor signaling, which may influence tumor behavior and treatment response.
Conclusion: While evidence supports routine thyroid monitoring and consideration of thyroid-sparing techniques in radiotherapy, conclusive data on the prognostic significance of hypothyroidism remain limited. Future prospective trials and mechanistic studies are essential to inform clinical guidelines and optimize personalized care.
References
Carvalho Neto EG, Gomes MF, Alves RPM, Santos APD, Brum C, Santin R. Anti-Ri autoimmune encephalitis associated with breast cancer. Arq Neuropsiquiatr. 2020;78(11):737.
Lin S, Wang Z, Xing M. Association Between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality. J Clin Endocrinol Metab. 2024;109(5):1222-30.
Tan H, Wang S, Huang F, Tong Z. Association between breast cancer and thyroid cancer risk: a two-sample Mendelian randomization study. Front Endocrinol (Lausanne). 2023;14:1138149.
Liu J, Liang L. The association between thyroid and breast cancers: a bidirectional mendelian randomization study. Front Endocrinol (Lausanne). 2023;14:1185497.
Koh HK, Park Y, Koo T, Cheong KH, Lee MY, Park HJ, et al. Association Between Thyroid Radiation Dose and Hypothyroidism in Breast Cancer Patients Undergoing Volumetric Modulated Arc Therapy for Regional Nodal Irradiation. In Vivo. 2023;37(5):2340-6.
Han M, Wang Y, Jin Y, Zhao X, Cui H, Wang G, et al. Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis. Front Endocrinol (Lausanne). 2022;13:984593.
Peckham M, Spencer HJ, Syed S, Armstrong WB, Farwell DG, Gal TJ, et al. Breast and thyroid cancer: A multicenter study with Accrual to Clinical Trials Network. J Surg Oncol. 2022;125(8):1211-7.
Tran TV, Rubino C, Allodji R, Andruccioli M, Bardet S, Diallo I, et al. Breast cancer risk among thyroid cancer survivors and the role of I-131 treatment. Br J Cancer. 2022;127(12):2118-24.
Park J, Kim C, Ki Y, et al. Incidence of hypothyroidism after treatment for breast cancer: A Korean population-based study. PLoS ONE. 2022;17. doi:10.1371/journal.pone.0269893
Digkas E, Smith D, Wennstig AK, et al. Incidence and risk factors of hypothyroidism after treatment for early breast cancer: a population-based cohort study. Breast Cancer Res Treat. 2023;204:79–87. doi:10.1007/s10549-023-07184-8
Hu X, Wang X, Liang Y, Chen X, Zhou S, Fei W, et al. Cancer Risk in Hashimoto's Thyroiditis: a Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2022;13:937871.
Sterle H, Hildebrandt X, Valenzuela Álvarez M, et al. Thyroid status regulates tumor microenvironment delineating breast cancer fate. Endocr Relat Cancer. 2021. doi:10.1530/ERC-20-0277
Trehan S, Cheng SS, Rawal A, et al. B-TREUH results: A single-arm phase II pilot study of euthyroid hypothyroxinemia in metastatic breast carcinoma. J Clin Oncol. 2023. doi:10.1200/jco.2023.41.16_suppl.e13111
McVicker L, Cardwell C, McIntosh S, McMenamin Ú. Cancer-specific mortality in breast cancer patients with hypothyroidism: a UK population-based study. Breast Cancer Res Treat. 2022;195:209–221. doi:10.1007/s10549-022-06674-5
Elgebaly MM, Abdel-Hamed A, Mesbah N, et al. Hypothyroidism affects progression and worse outcomes of breast cancer but not ovarian cancer. J Immunoassay Immunochem. 2021;43:288–298. doi:10.1080/15321819.2021.2001003
Huang H, Roberson J, Hou W, et al. NTCP model for hypothyroidism after supraclavicular-directed radiation therapy for breast cancer. Radiother Oncol. 2020. doi:10.1016/j.radonc.2020.09.003
Peixoto MS, Souza AVE, Andrade IS, et al. Hypothyroidism induces oxidative stress and DNA damage in breast. Endocr Relat Cancer. 2021. doi:10.1530/ERC-21-0010
Halada S, Casado-Medrano V, Baran JA, Lee J, Chinmay P, Bauer AJ, et al. Hormonal Crosstalk Between Thyroid and Breast Cancer. Endocrinology. 2022;163(7).
Yang H, Holowko N, Grassmann F, Eriksson M, Hall P, Czene K. Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors. BMC Med. 2020;18(1):225.
Marina D, Rasmussen Å K, Buch-Larsen K, Gillberg L, Andersson M, Schwarz P. Influence of the anti-oestrogens tamoxifen and letrozole on thyroid function in women with early and advanced breast cancer: A systematic review. Cancer Med. 2023;12(2):967-82.
Lu Y, Ma L. Investigation of the causal relationship between breast cancer and autoimmune diseases: A bidirectional mendelian randomization study. Medicine (Baltimore). 2023;102(34):e34612.
Wang M, Gong WW, He QF, Hu RY, Yu M. Menstrual, reproductive and hormonal factors and thyroid cancer: a hospital-based case-control study in China. BMC Womens Health. 2021;21(1):13.
Bonfiglio R, Granaglia A, Giocondo R, Scimeca M, Bonanno E. Molecular Aspects and Prognostic Significance of Microcalcifications in Human Pathology: A Narrative Review. Int J Mol Sci. 2020;22(1).
Fu J, He M, Wu Q, Zhang X, Qi X, Shen K, et al. The clinical and genetic features in patients coexisting primary breast and thyroid cancers. Front Endocrinol (Lausanne). 2023;14:1136120.
Bakos B, Kiss A, Árvai K, Szili B, Deák-Kocsis B, Tobiás B, et al. Co-occurrence of thyroid and breast cancer is associated with an increased oncogenic SNP burden. BMC Cancer. 2021;21(1):706.
Bolf EL, Gillis NE, Davidson CD, Cozzens LM, Kogut S, Tomczak JA, et al. Common tumor-suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells. Mol Carcinog. 2021;60(12):874-85.
Zheng Y, Tang H, Wu J, Guan D, Mo Q, Zheng Q. The crosstalk between benign thyroid disease and breast cancer: A single center study. Medicine (Baltimore). 2024;103(10):e37298.
Schubert SA, Ruano D, Joruiz SM, Stroosma J, Glavak N, Montali A, et al. Germline variant affecting p53β isoforms predisposes to familial cancer. Nat Commun. 2024;15(1):8208.
Baron JA, Nichols HB, Anderson C, Safe S. Cigarette Smoking and Estrogen-Related Cancer. Cancer Epidemiol Biomarkers Prev. 2021;30(8):1462-71.
Worapongpaiboon R, Vongsaisuwon M. Breast metastasis of papillary thyroid carcinoma. BMJ Case Rep. 2022;15(7).
Solmunde E, Falstie-Jensen AM, Lorenzen EL, Ewertz M, Reinertsen KV, Dekkers OM, et al. Breast cancer, breast cancer-directed radiation therapy and risk of hypothyroidism: A systematic review and meta-analysis. Breast. 2023;68:216-24.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Irfan Ishaque, Zainab Zikria, Maida Zafar , Manahil Rashid , Iram Saddiqa Aamir , Ramaz Rashid , Eman Aslam , Summyya Rasheed (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
